Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.28
+0.08 (0.27%)
At close: Mar 4, 2026, 4:00 PM EST
29.38
+0.10 (0.34%)
After-hours: Mar 4, 2026, 6:50 PM EST
Alkermes Employees
Alkermes had 2,050 employees as of December 31, 2025. The number of employees increased by 250 or 13.89% compared to the previous year.
Employees
2,050
Change (1Y)
250
Growth (1Y)
13.89%
Revenue / Employee
$719,951
Profits / Employee
$117,885
Market Cap
4.88B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,300 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 674 |
ALKS News
- 7 days ago - Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 - Business Wire
- 7 days ago - Alkermes plc Announces CEO Succession Plan - Business Wire
- 8 days ago - Alkermes to Present at the TD Cowen 46th Annual Health Care Conference - Business Wire
- 20 days ago - Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - Business Wire
- 21 days ago - Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Business Wire
- 7 weeks ago - Alkermes plc (ALKS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Alkermes: Avadel Deal And Vibrance-2 Unlock Upside - Seeking Alpha